5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Nath Bio-Genes (India) Ltd.

•
nathbiogenes.comBSE: 537291NSE: NATHBIOGEN
Market Cap₹ 281 Cr.
Current Price
High / Low₹ 204 / 126
Stock P/E5.9
Book Value₹ 380
Price to Book0.43
Dividend Yield1.35 %
ROCE7.3 %
ROE6.7 %
Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2025 • Agriculture Activities: 87.4% • Trading Activity: 12.6%

AI Sector View

AI GENERATED

Fast Moving Consumer Goods

Hold

Rural demand proxies are mixed. Tractor sales rose 18.0% YoY (2026-07) and 2-wheelers were up 23.0% YoY (2026-06), but rural employment slowed to 1.0% YoY (2026-07), fertiliser sales were 0.0% YoY (2026-05), and food inflation of 5.52% (Jul/26) can pressure household budgets. FPI outflows remain heavy at INR -8081 crore over 3 months to 2026-08-31, limiting upside.

Confidence
62%
View full sector analysis →

PROS

  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.19x)
  • Company generates healthy free cash flow
  • Company has a consistent dividend-paying track record
  • Company maintains a comfortable, low leverage position

CONS

  • Recent results are weak - TTM profit is down 32.6% versus prior year
  • Company has a low return on capital employed of 7.2%
  • Company has a low return on equity of 6.6% over last 3 years
  • Company has delivered a poor profit growth of -3.5% over past five years
  • Effective tax rate is unusually low at 4.5% - earnings may be flattered
  • Company has delivered a poor sales growth of 5.3% over past five years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

Fast Moving Consumer GoodsAgriAgriculture
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.KSCL715.7514.753681.750.00279.84-14.47742.50-13.5121.7739.58
2.VENKEYS1786.55366.342516.770.5649.99215.791118.3829.1711.276.18
3.AVTNPL89.9616.351369.950.8931.10156.69241.2282.1614.2616.56
4.BSHSL90.0032.92944.440.0014.3016.56182.5719.3721.199.39
5.REGAAL83.8314.43863.400.3013.3346.95202.15-18.0216.9115.33
6.MGEL15.9411.13525.310.0684.261210.019520.651008.9319.371.94
7.NATHBIOGEN147.807.67280.881.3532.26-13.46328.4015.766.8910.70
8.MSL149.0019.67163.600.003.971.9361.8425.8112.349.28
9.INDOUS77.6130.74155.620.003.04-35.3832.997.2121.1512.01
10.OSWALSEEDS15.5411.64142.140.0012.2768.60117.0819.539.8815.65
11.NARMADA14.3130.22108.570.007.54—222.63—8.944.25
12.AGRITECH99.950.0059.370.00-3.6161.180.00—-0.94—
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
235233243244323749280406646323
198172639207262946241335739293
Operating Profit37564377733979730
OPM %15.79%22.55%18.24%10.41%15.20%20.38%20.34%6.42%13.88%18.08%13.39%14.47%9.38%
0030000422441
Interest3231233133434
Depreciation1111111111111
Profit before Tax34253343453758633
Tax %0.65%17.86%16.31%21.60%0.73%-1.05%30.08%13.12%1.79%13.22%10.74%39.75%2.16%
Net Profit34242343343647433
17.580.852.092.1817.771.461.402.1220.062.163.802.1717.18

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
162170192231280308278301333362474
137141151188225241241252282310421
Operating Profit2529404355673749505253
OPM %15.20%17.07%21.11%18.78%19.58%21.71%13.39%16.31%15.17%14.46%11.16%
111222-8714511
Interest61010579111091014
Depreciation43111333344
Profit before Tax151730394957-6336424453
Tax %6.04%2.81%2.12%1.12%-4.07%1.92%-6.23%3.17%4.62%4.50%8.99%
Net Profit141629385056-6735404248
EPS0.000.000.000.000.0029.00-35.5218.5121.1422.17—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%6.83%-5.64%10.81%9.46%9.02%—

COMPOUNDED SALES GROWTH

10 Years:
7%
5 Years:
5%
3 Years:
9%

COMPOUNDED PROFIT GROWTH

10 Years:
5%
5 Years:
-4%
3 Years:
—

STOCK PRICE CAGR

10 Years:
4%
5 Years:
-15%
3 Years:
-11%
1 Year:
-13%

RETURN ON EQUITY

10 Years:
6%
5 Years:
4%
3 Years:
7%
Last Year:
7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Sep 11

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2025

Aug 14

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2024

Aug 9

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2023

Jul 4

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2022

Jun 23

₹ 0.20

Rs.2.0000 per share(20%)Dividend

2021

Aug 18

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2026

Sep 7

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital16161919191919191919
105287450489539594523554592630
58693258709992104107110
Trade Payables48443750683543284279
3938323234426387117180
Total Liabilities2664545706487297907407938771,017
30207211232246247245244249250
5555555566
141130123155204226220208229331
000000009489
Cash & Bank16452122294387688
88106186234252282265298223253
Total Assets2664545706487297907407938771,017

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
-143-47-2011120397527
Cash from Investing-17-4-4-20-14-10-20-3-27-4
Cash from Financing3059020616-22-2-10-11
-0539-2317-25343812

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
45.6045.6045.6045.6045.6045.6045.6045.6045.60
0.210.180.190.210.410.320.310.220.26
4.374.374.373.942.250.760.010.010.01
Government0.000.000.000.000.000.000.000.000.00
49.8249.8549.8450.2551.7453.3254.0854.1754.13

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-09
Clarification - Financial Results

2026-09-09 - The Exchange has sought clarification from Nath Bio-Genes (India) Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.

2026-09-01
Record Date

2026-09-01 - Nath Bio-Genes (India) Limited has informed the Exchange that Record date for the purpose of Dividend & Meeting is 11-Sep-2026.

2026-09-01
Shareholders meeting

2026-09-01 - Nath Bio-Genes (India) Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026

2026-08-06
Initiation of Forensic Audit

2026-08-06 - Nath Bio-Genes (India) Limited has informed the Exchange about Initiation of Forensic Audit

2026-07-30
General Updates

2026-07-30 - Nath Bio-Genes (India) Limited has informed the Exchange about General Updates

2026-07-29
Outcome of Board Meeting

2026-07-29 - Nath Bio-Genes (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-07-23
Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-07-23 - Nath Bio-Genes (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-06-26
Trading Window

2026-06-26 - Nath Bio-Genes (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

2026-06-19
Disclosure under SEBI Takeover Regulations

2026-06-19 - Nath Bio-Genes (India) Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

News

Recent coverage and analyst commentary for NATHBIOGEN

Loading news…

🤖

AI Stock Analyst

Nath Bio-Genes (India) Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login